New Federal Contractors — September 22, 2026

QTC Medical Services, a Leidos subsidiary, received a $240.6 million firm-fixed-price delivery order from the VA for medical evaluation services, with $233.6 million (97%) already outlayed. This high utilization rate suggests strong contract execution and potential for follow-on awards, positioning Leidos favorably in the VA healthcare services market.

The $240.6 million firm-fixed-price delivery order carries medium pricing risk, as cost overruns could impact margins. The one-year performance period (Oct 2023–Sep 2024) is complete, and any disputes or modifications could affect the remaining outlay.

The VA's sustained spending on medical evaluations, evidenced by this $240.6 million award, suggests stable or growing demand. Leidos, through QTC, could capture follow-on task orders or new VA contracts, especially given the competitive win under full and open competition.

The VA's $240.6 million award to QTC Medical Services for medical evaluations underscores stable, non-discretionary spending in veteran healthcare. This contract, with 97% funding utilization, highlights the reliability of civilian health services budgets.

{"entity" => "Leidos Holdings", "reason" => "QTC Medical Services, a Leidos subsidiary, secured a $240.6 million VA contract with high funding utilization, indicating strong execution and potential for follow-on work.", "trigger" => "VA's FY25 budget approval and any re-compete announcements for medical evaluation services"}